| 0 | 💬 0 |
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC.
(nejm.org)
|
New England Journal of Medicine 2026-01-01 | #clinical trial #chemotherapy #nsclc #targeted therapy #egfr |